title: [ACE inhibitors--a potential new group of drugs for treatment of kidney diseases].
abstract: ACE inhibitors, which till recently were used almost exclusively for treatment of cardiovascular diseases, are becoming a perspective group of drugs also in the treatment of nephropathies. It was found that they are effective in particular in the treatment of proteinuria of varying origin and have also a marked renoprotective effect and are therefore recommended to retard progression of renal failure. They reduce intraglomerular hypertension, increase glomerular filtration and the renal blood flow, and it is assumed that they can retard progression of chronic glomerulonephritis and diabetic nephropathy. We may expect already in the near future that their therapeutic application will be substantially extended also in clinical nephrology.
authors: Detská klinika LF UPJS, Kosice.
authors: L
authors: L
authors: Podracká
authors: M
authors: M
authors: Sasinka
authors: A
authors: A
authors: Böör
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000503:physiopathology
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors
vernacular_title: Inhibitory ACE--nová perspektivna skupina liekov v terapii oblickových chorôb.